Cola Michael F
- SEC CIK
- 0001188940
No open-market purchases or sales filed in the past year.
Current role at each company
- PHAT Phathom Pharmaceuticals, Inc.Directoras of May 21, 2026
- SAGE Sage Therapeutics, Inc.Directoras of Jul 31, 2025
- AVTX Avalo Therapeutics, Inc.Chief Executive Officeras of Oct 4, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cola Michael F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PHAT Phathom Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2022 (view filing) | Oct 29, 2019 | 843 daysLate | Cola Michael FDirector | PPurchase | +9.80K | $19.00 | +$186.2K | New position9.80K after |